| Board Member | Position | Affiliation |
|---|---|---|
|
Professor of Biochemical Engineering; Head of the Institute for Chemical and Bioengineering |
Department of Chemistry and Applied Biosciences, ETH Zurich | |
|
Senior VP, Head of Platform & Chemical Biology |
Matchpoint Therapeutics, USA | |
|
Senior Director |
Ellison Institute of Technology Oxford | |
|
Head of Physics and Astronomy; Professor of Molecular and Nanoscale Physics |
School of Physics & Astronomy, University of Leeds, UK | |
| NED, Advisor & Venture Partner in Technology and Innovation | Merian Ventures; UKRI, UK | |
| SVP Research | Insmed Incorporated, USA | |
| Principal Investigator | Dana-Farber Cancer Institute, USA | |
| Professor of Computational Microbiology | Department of Biochemistry, University of Oxford | |
| Founder and co-CEO | Sixfold Bioscience, UK | |
| Head of Organic Chemistry and Chemical Biology | Department of Chemistry, University College London, UK | |
| Founder and CEO |
Esya Labs |
|
| Director of the ICB CDT; Professor of Plant Chemical Biology | Department of Chemistry, 天美传媒, UK | |
| Co-Director of the ICB CDT; Professor of Membrane Biophysics | Department of Chemistry, 天美传媒, UK | |
| Professor Oscar Ces | Head of Department of Chemistry; August von Hofmann Chair of Chemistry | Department of Chemistry, 天美传媒, UK |
| Institute of Chemical Biology and CDT Manager | Department of Chemistry, 天美传媒, UK | |
| Co-Director of the ICB CDT; GSK Chair in Chemical Biology | Department of Chemistry, 天美传媒, UK | |
| Dr Rudiger Woscholski | Co-Director of the ICB CDT; Reader in Chemical Biology | Department of Chemistry, 天美传媒, UK |
| Board meetings are also attended by representatives of the EPSRC and CDT 天美传媒 | ||
